InSphero's team of scientists is spanning applications from early development phases to post-market in vitro studies leveraging the power of 3D cell culture technologies. Our research team has validated and optimized 3D-cell-based technology assays and endpoints for several applications within the drug discovery and development cycle.
InSphero scientists work with biopharmaceutical and life science companies, academia, and regulatory/governmental authorities to develop 3D in vitro models and technology platforms in drug discovery and drug development.
When you invest in 3D InSight™ discovery and safety platforms, you gain access to:
- our proven 3D InSight™ organoids,
- specially formulated media,
- rigorously tested inducers,
- 3D-optimized technical protocols
- and expert support services for these certified applications.
Research Areas
Metabolic Disease
β-cell Function & Insulin Secretagogues
α-cell Function & Glucagon Suppressors
Islet Viability & Apoptosis
β-cell Proliferation
Diabetes Type 1 & Type 2 Models
Dynamic Insulin Secretion
Drug-induced Pancreatic Endocrine Injury